Retroviral transduction of human dendritic cells with a tumor-associated antigen gene.

scientific article published in December 1996

Retroviral transduction of human dendritic cells with a tumor-associated antigen gene. is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID8971174

P50authorSteven RosenbergQ2347448
P2093author name stringLam JS
Hwu P
Royal RE
Reeves ME
P433issue24
P407language of work or nameEnglishQ1860
P921main subjectdendritic cellQ506253
P304page(s)5672-5677
P577publication date1996-12-01
P1433published inCancer ResearchQ326097
P1476titleRetroviral transduction of human dendritic cells with a tumor-associated antigen gene
P478volume56

Reverse relations

cites work (P2860)
Q37189574An effective vaccine against colon cancer in mice: use of recombinant adenovirus interleukin-12 transduced dendritic cells
Q42925679Antitumor Vaccines Based on Dendritic Cells: From Experiments using Animal Tumor Models to Clinical Trials
Q40834747Can immunotherapy by gene transfer tip the balance against colorectal cancer?
Q36380749Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity
Q36380718Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases
Q39612180Development of minimal lentivirus vectors derived from simian immunodeficiency virus (SIVmac251) and their use for gene transfer into human dendritic cells
Q55473331Effects of glioma cells on maturation of dendritic cells.
Q35039002Gene-modified dendritic cells for immunotherapy against cancer
Q41687574Human tumor antigens recognized by T-cells
Q36908547Hybrids of dendritic cells and tumor cells generated by electrofusion simultaneously present immunodominant epitopes from multiple human tumor-associated antigens in the context of MHC class I and class II molecules
Q28347565In vitro generation of human CD86+ dendritic cells from CD34+ haematopoietic progenitors by PMA and in serum-free medium
Q34792069Induction of CD4(+) T cell-dependent antitumor immunity by TAT-mediated tumor antigen delivery into dendritic cells
Q51240658Isolation and transduction of monocytes: promising vehicles for therapeutic arteriogenesis.
Q47287396Lentiviral gp34/OX40L gene transfer into dendritic cells facilitates alloreactive CD4+ T-cell response in vitro
Q46899687MART-1 adenovirus-transduced dendritic cell immunization in a murine model of metastatic central nervous system tumor
Q35159565Macrophage inflammatory protein 3alpha transgene attracts dendritic cells to established murine tumors and suppresses tumor growth
Q41788640Mapping the HLA-A24-restricted T-cell epitope peptide from a tumour-associated antigen HER2 / neu: possible immunotherapy for colorectal carcinomas
Q38744180Optimized protocol for efficient transfection of dendritic cells without cell maturation
Q38832705Optimizing the process of nucleofection for professional antigen presenting cells
Q34030512Potential applications of gene therapy in the patient with cancer
Q36327106Presentation of tumor antigens by dendritic cells genetically modified with viral and nonviral vectors
Q37055696TLR-independent type I interferon induction in response to an extracellular bacterial pathogen via intracellular recognition of its DNA.
Q64381308Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells
Q36438078Tumor antigens discovery: perspectives for cancer therapy
Q38468370Validation of efficient high-throughput plasmid and siRNA transfection of human monocyte-derived dendritic cells without cell maturation

Search more.